| Jane Phillips Regional Home Care, Llc | |
| 219 Nw Virginia Avenue, Bartlesville, Oklahoma 74003 | |
| (918) 907-3010 | |
| Name | Jane Phillips Regional Home Care, Llc |
|---|---|
| Location | 219 Nw Virginia Avenue, Bartlesville, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377272 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 74001, 74002, 74003, 74006, 74016, 74021, 74022, 74027, 74029, 74035, 74048, 74051, 74053, 74055, 74056, 74061, 74070, 74072, 74080, 74082, 74083, 74084 |
| NPI Number | 1750425104 |
| Organization Name | JANE PHILLIPS REGIONAL HOME CARE, LLC. |
| Doing Business As | ASCENSION AT HOME |
| Address | 3061 Se Washington Blvd, Bartlesville, OK 74006 |
| Phone Number | 918-907-3010 |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
| Quality Rating: |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.3 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 89 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 91.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.2 | 96.4 |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.7 | 79.6 |
| How often patients got better at getting in and out of bed | 83.6 | 81.1 |
| How often patients got better at bathing | 86.6 | 82.3 |
| How often patients’ breathing improved | 86.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 100 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 79.5 | 75 |
| How often home health patients had to be admitted to the hospital | 12.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 18.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.5 | 94 |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
The patient survey data of Jane Phillips Regional Home Care, Llc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 86 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 73 | 78 |
News Archive
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer - and they believe it could be exploited as a target to develop new treatment strategies.
› Verified 9 days ago
Amedisys Home Health Location: 2503 Se Washington Blvd, Suite 4, Bartlesville, Oklahoma 74006 Ratings: Phone: (918) 333-2802 | |
Jane Phillips Regional Home Care, Llc Location: 219 Nw Virginia Avenue, Bartlesville, Oklahoma 74003 Ratings: Phone: (918) 907-3010 | |
Shanadoa Home Health Inc Location: 2633 Se Mission Drive, Ste 128, Bartlesville, Oklahoma 74006 Ratings: Phone: (918) 331-0800 |